Report on epoetin use in oncology is precursor to guidelines.
Levenson
D
D
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D001803:Blood Transfusion; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use; D006454:Hemoglobins / Q000187:drug effects; D006801:Humans; D008495:Medical Oncology; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D011994:Recombinant Proteins; D014481:United States; D016270:United States Agency for Healthcare Research and Quality
D006397:Hematinics; D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa